23C Stock Overview
Engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
QT Imaging Holdings, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.11 |
52 Week High | US$3.64 |
52 Week Low | US$1.11 |
Beta | -0.11 |
11 Month Change | 0% |
3 Month Change | -10.38% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -68.53% |
Recent News & Updates
Recent updates
Shareholder Returns
23C | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 0% | -2.3% | 0.2% |
1Y | n/a | -1.5% | 7.6% |
Return vs Industry: Insufficient data to determine how 23C performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how 23C performed against the German Market.
Price Volatility
23C volatility | |
---|---|
23C Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 4.9% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 11.9% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 23C's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 23C's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 12 | Raluca Dinu | www.qtimaging.com |
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.
QT Imaging Holdings, Inc. Fundamentals Summary
23C fundamental statistics | |
---|---|
Market cap | €13.77m |
Earnings (TTM) | -€7.81m |
Revenue (TTM) | €1.28m |
10.8x
P/S Ratio-1.8x
P/E RatioIs 23C overvalued?
See Fair Value and valuation analysisEarnings & Revenue
23C income statement (TTM) | |
---|---|
Revenue | US$1.39m |
Cost of Revenue | US$690.49k |
Gross Profit | US$704.46k |
Other Expenses | US$9.22m |
Earnings | -US$8.51m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.40 |
Gross Margin | 50.50% |
Net Profit Margin | -610.39% |
Debt/Equity Ratio | -180.5% |
How did 23C perform over the long term?
See historical performance and comparison